Carotenoids: How effective are they to prevent age-related diseases?

Molecules

Volumn 24, Issue 9, 2019, Pages

  Tan, Bee Ling ^a   Norhaizan, Mohd Esa ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Aging; Cancer; Cardiovascular disease; Dementia; Diabetes; Inflammation; Oxidative stress

Indexed keywords

CAROTENOID;

AGING; BIOAVAILABILITY; CHEMISTRY; DIET; DISEASES; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

AGING; BIOLOGICAL AVAILABILITY; CAROTENOIDS; DIET; DISEASE; HUMANS; OXIDATIVE STRESS;

EID: 85065860634     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules24091801     Document Type: Review

References (205)

1. World Health Organization. Global Health Observatory (GHO) data, Life Expectancy. 2019. Available online: Https://www.who.int/gho/mortality_burden_disease/life_tables/en/ (accessed on 3 March 2019).
2. World Health Organization. World Health Statistics-Large Gains in Life Expectancy. 2014. Available online: Http://www.who.int/mediacentre/news/releases/2014/world-health-statistics-2014/en/ (accessed on 3 March 2019).
3. Bruins, M.J.; Van Dael, P.; Eggersdorfer, M. The role of nutrients in reducing the risk for noncommunicable diseases during aging. Nutrients 2019, 11, 85. [CrossRef] [PubMed]
4. Jin, K.; Simpkins, J.W.; Ji, X.; Leis, M.; Stambler, I. The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population. Aging Dis. 2015, 6, 1. [CrossRef]
5. Rahal, A; Kumar, A.; Singh, V.; Yadav, B.; Tiwari, R.; Chakraborty, S.; Dhama, K. Oxidative stress, prooxidants, and antioxidants: The interplay. BioMed Res. Int. 2014, 2014. [CrossRef]
6. Gudkov, S.V.; Guryev, E.L.; Gapeyev, A.B.; Sharapov, M.G.; Bunkin, N.F.; Shkirin, A.V.; Zabelina, T.S.; Glinushkin, A.P.; Sevost'yanov, M.A.; Belosludtsev, K.N.; et al. Unmodified hydrated C60 fullerene molecules exhibit antioxidant properties, prevent damage to DNA and proteins induced by reactive oxygen species and protect mice against injuries caused by radiation-induced oxidative stress. Nanomedicine 2019, 15, 37-46. [CrossRef] [PubMed]
7. Giudetti, A.M.; Salzet, M.; Cassano, T. Oxidative stress in aging brain: Nutritional and pharmacological interventions for neurodegenerative disorders. Oxid. Med. Cell. Longev. 2018, 2018. [CrossRef]
8. Tan, B.L.; Norhaizan, M.E.; Huynh, K.; Heshu, S.R.; Yeap, S.K.; Hazilawati, H.; Roselina, K. Water extract of brewers' rice induces apoptosis in human colorectal cancer cells via activation of caspase-3 and caspase-8 and downregulates the Wnt/β-catenin downstream signaling pathway in brewers' rice-treated rats with azoxymethane-induced colon carcinogenesis. BMC Complement. Altern. Med. 2015, 15, 205.
9. Liu, Z.; Zhou, T.; Ziegler, A.C.; Dimitrion, P.; Zuo, L. Oxidative stress in neurodegenerative diseases: From molecular mechanisms to clinical applications. Oxid. Med. Cell. Longev. 2017, 2017. [CrossRef]
10. Chistiakov, D.A.; Sobenin, I.A.; Revin, V.V.; Orekhov, A.N.; Bobryshev, Y.V. Mitochondrial aging and age-related dysfunction of mitochondria. BioMed Res. Int. 2014, 2014. [CrossRef]
11. Eckmann, J.; Eckert, S.H.; Leuner, K.; Muller, W.E.; Eckert, G.P. Mitochondria: Mitochondrial membranes in brain ageing and neurodegeneration. Int. J. Biochem. Cell Biol. 2013, 45, 76-80. [CrossRef] [PubMed]
12. Liguori, I.; Russo, G.; Curcio, F.; Bulli, G.; Aran, L.; Della-Morte, D.; Gargiulo, G.; Testa, G.; Cacciatore, F.; Bonaduce, D.; et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging. 2018, 13, 757-772. [CrossRef] [PubMed]
13. Maulik, N.; McFadden, D.; Otani, H.; Thirunavukkarasu, M.; Parinandi, N.L. Antioxidants in longevity and medicine. Oxid. Med. Cell. Longev. 2013, 2013. [CrossRef] [PubMed]
14. Corbi, G.; Acanfora, D.; Iannuzzi, G.L.; Longobardi, G.; Cacciatore, F.; Furgi, G.; Filippelli, A.; Rengo, G.; Leosco, D.; Ferrara, N. Hypermagnesemia predicts mortality in elderly with congestive heart disease: Relationship with laxative and antacid use. Rejuvenation Res. 2008, 11, 129-138. [CrossRef]
15. Stadtman, E.R.; Berlett, B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 1997, 10, 485-494. [CrossRef] [PubMed]
16. López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The hallmarks of aging. Cell 2013, 153, 1194-1217.
17. Dias, V.; Junn, E.; Mouradian, M.M. The role of oxidative stress in Parkinson's disease. J. Parkinson's Dis. 2013, 3, 461-491.
18. Zuo, L.; Zhou, T.; Pannell, B.K.; Ziegler, A.; Best, T.M. Biological and physiological role of reactive oxygen species-the good, the bad and the ugly. Acta Physiol. 2015, 214, 329-348. [CrossRef]
19. Tan, B.L.; Norhaizan, M.E.; Liew, W.-P.P.; Rahman, H.S. Antioxidant and oxidative stress: A mutual interplay in age-related diseases. Front. Pharmacol. 2018, 9, 1162. [CrossRef]
20. Cheng, H.M.; Koutsidis, G.; Lodge, J.K.; Ashor, A.W.; Siervo, M.; Lara, J. Lycopene and tomato and risk of cardiovascular diseases: A systematic review and meta-analysis of epidemiological evidence. Crit. Rev. Food Sci. Nutr. 2019, 59, 141-158. [CrossRef] [PubMed]
21. Palozza, P.; Catalano, A.; Simone, R.E.; Mele, M.C.; Cittadini, A. Effect of lycopene and tomato products on cholesterol metabolism. Ann. Nutr. MeTable 2012, 61, 126-134. [CrossRef] [PubMed]
22. Hoang, D.V.; Pham, N.M.; Lee, A.H.; Tran, D.N.; Binns, C.W. Dietary carotenoid intakes and prostate cancer risk: A case-control study from Vietnam. Nutrients 2018, 10, 70. [CrossRef]
23. Hou, L.L.; Gao, C.; Chen, I.; Hu, G.Q.; Xie, S.Q. Essential role of autophagy in fucoxanthin-induced cytotoxicity to human epithelial cervical cancer HeLa cells. Acta Pharmacol. Sin. 2013, 34, 1403-1410. [CrossRef]
24. Satomi, Y. Antitumor and cancer-preventative function of fucoxanthin: A marine carotenoid. Anticancer Res. 2017, 37, 1557-1562. [CrossRef]
25. Alós, E.; Rodrigo, M.J.; Zacarias, L. Manipulation of carotenoid content in plants to improve human health. In Carotenoids in Nature; Springer: Cham Switzerland, 2016; pp. 311-343.
26. Du, X.; Song, K.; Wang, J.; Cong, R.; Li, L.; Zhang, G. Draft genome and SNPs associated with carotenoid accumulation in adductor muscles of bay scallop (Argopecten irradians). J. Genomics 2017, 5, 83. [CrossRef]
27. Singh, G.; Sahota, H.K. Impact of benzimidazole and dithiocarbamate fungicides on the photosynthetic machinery, sugar content and various antioxidative enzymes in chickpea. Plant Physiol. Biochem. 2018, 132, 166-173. [CrossRef]
28. Gauger, T.; Konhauser, K.; Kappler, A. Protection of phototrophic iron (II)-oxidizing bacteria from UV irradiation by biogenic iron (III) minerals: Implications for early Archean banded iron formation. Geology 2015, 43, 1067-1070. [CrossRef]
29. Paliwal, C.; Ghosh, T.; George, B.; Pancha, I.; Maurya, R.; Chokshi, K.; Ghosh, A.; Mishra, S. Microalgal carotenoids: Potential nutraceutical compounds with chemotaxonomic importance. Algal Res. 2016, 15, 24-31. [CrossRef]
30. Khachik, F. Distribution and metabolism of dietary carotenoids in humans as a criterion for development of nutritional supplements. Pure Appl. Chem. 2006, 78, 1551-1557. [CrossRef]
31. Parker, R.S. Carotenoids in human blood and tissues. J. Nutr. 1989, 119, 101-104. [CrossRef]
32. Yaroshevich, I.; Krasilnikov, P.; Rubin, A. Functional interpretation of the role of cyclic carotenoids in photosynthetic antennas via quantum chemical calculations. Comput. Theor. Chem. 2015, 1070, 27-32. [CrossRef]
33. Berman, J.; Zorrilla-López, U.; Farré, G.; Zhu, C.; Sandmann, G.; Twyman, R.M.; Capell, T.; Christou, P. Nutritionally important carotenoids as consumer products. Phytochem. Rev. 2015, 14, 727-743. [CrossRef]
34. Harrison, E.H.; Curley, R.W. Carotenoids and retinoids: Nomenclature, chemistry, and analysis. In The Biochemistry of Retinoid Signaling II; Springer: Dordrecht, the Netherlands, 2016; pp. 1-19.
35. Gabriel, H.B.; Silva, M.F.; Kimura, E.A.; Wunderlich, G.; Katzin, A.M.; Azevedo, M.F. Squalestatin is an inhibitor of carotenoid biosynthesis in Plasmodium falciparum. Antimicrob. Agents Chemother. 2015, 59, 3180-3188. [CrossRef] [PubMed]
36. Fiedor, J.; Burda, K. Potential role of carotenoids as antioxidants in human health and disease. Nutrients 2014, 6, 466-488. [CrossRef]
37. Nishino, A.; Yasui, H.; Maoka, T. Reaction of paprika carotenoids, capsanthin and capsorubin, with reactive oxygen species. J. Agric. Food Chem. 2016, 64, 4786-4792. [CrossRef]
38. Langi, P.; Kiokias, S.; Varzakas, T.; Proestos, C. Carotenoids: From plants to food and feed industries. In Microbial Carotenoids. Methods in Molecular Biology; Barreiro, C., Barredo, J.L., Eds.; Humana Press: New York, NY, USA, 2018; Volume 1852, pp. 57-71.
39. Johnson, E.J. The role of carotenoids in human health. Nutr. Clin. Care 2002, 5, 56-65. [CrossRef]
40. Yahia, E.M.; Ornelas-Paz, J.d.J. Chemistry, stability, and biological actions of carotenoids. In Fruit and Vegetable Phytochemicals Chemistry, Nutritional Value and Stability; de la Rosa, L.A., Alvarez-Parrilla, E., González-Aguilar, G.A., Eds.; Wiley-Blackwell: Ames, IA, USA, 2010; pp. 177-222.
41. Lin, Q.; Liang, R.; Williams, P.A.; Zhong, F. Factors affecting the bioaccessibility of β-carotene in lipid-based microcapsules: Digestive conditions, the composition, structure and physical state of microcapsules. Food Hydrocoll. 2018, 77, 187-203. [CrossRef]
42. Thane, C.; Reddy, S. Processing of fruits and vegetables: Effect on carotenoids. Nutr. Food Sci. 1997, 2, 58-65. [CrossRef]
43. Hart, D.J.; Scott, K.J. Development and evaluation of an HPLC method for the analysis of carotenoids in foods, and the measurement of the carotenoid content of vegetables and fruits commonly consumed in the UK. Food Chem. 1995, 54, 101-111. [CrossRef]
44. Calva, M.M. Lutein: A valuable ingredient of fruit and vegetables. Crit. Rev. Food Sci. Nutr. 2005, 45, 671-696. [CrossRef] [PubMed]
45. Van den Berg, H.; Faulks, R.; Granado, H.F.; Hirschberg, J.; Olmedilla, B.; Sandmann, G.; Southon, S.; Stahl, W. The potential for the improvement of carotenoid levels in foods and the likely systemic effects. J. Sci. Food Agric. 2000, 80, 880-912. [CrossRef]
46. Granado, F.; Olmedilla, B.; Blanco, I.; Rojas-Hidalgo, E. Carotenoid composition in raw and cooked Spanish vegetables. J. Agric. Food Chem. 1992, 40, 2135-2140. [CrossRef]
47. US Department of Agriculture, Agricultural Research Service, Nutrient Data Laboratory. USDA National Nutrient Database for Standard Reference. 2016. Available online: Http://www.ars.usda.gov/ba/bhnrc/ndl (accessed on 15 March 2016).
48. Maiani, G.; Periago Caston, M.J.; Catasta, G.; Toti, E.; Cambrodon, I.G.; Bysted, A.; Granado-Lorencio, F.; Olmedilla-Alonso, B.; Knuthsen, P.; Valoti, M.; et al. Carotenoids: Actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol. Nutr. Food Res. 2009, 53, S194-S218. [CrossRef]
49. Marinova, D.; Ribarova, F. HPLC determination of carotenoids in Bulgarian berries. J. Food Comp. Anal. 2007, 20, 370-374. [CrossRef]
50. Perry, A.; Rasmussen, H.; Johnson, E. Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and egg products. J. Food Comp. Anal. 2009, 22, 9-15. [CrossRef]
51. Kimura, M.; Rodriguez-Amaya, D.B. Carotenoid composition of hydroponic leafy vegetables. J. Agric. Food Chem. 2003, 51, 2603-2607. [CrossRef]
52. Setiawan, B.; Sulaeman, A.; Giraud, D.W.; Driskell, J.A. Carotenoid content of selected Indonesian fruits. J. Food Compost. Anal. 2001, 14, 169-176. [CrossRef]
53. Lee, H.S.; Coates, G.A. Effect of thermal pasteurization on Valencia orange juice color and pigments. LWT Food Sci. Technol. 2003, 36, 153-156. [CrossRef]
54. Marín, A.; Ferreres, F.; Tomás-Barberán, F.A.; Gil, M.I. Characterization and quantitation of antioxidant constituents of sweet pepper (Capsicum annuum L.). J. Agric. Food Chem. 2004, 52, 3861-3869.
55. Ameny, M.A.; Wilson, P.W. Relationship between hunter color values and β-carotene contents in white-fleshed African sweet potatoes (Ipomoea batatas Lam). J. Sci. Food Agric. 1997, 73, 301-306. [CrossRef]
56. Brown, M.J.; Ferruzzi, M.G.; Nguyen, M.L.; Cooper, D.A.; Eldridge, A.L.; Schwartz, S.J.; White, W.S. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am. J. Clin. Nutr. 2004, 80, 396-403. [CrossRef] [PubMed]
57. Ghavami, A.; Coward, W.A.; Bluck, L.J. The effect of food preparation on the bioavailability of carotenoids from carrots using intrinsic labelling. Br. J. Nutr. 2012, 107, 1350-1366. [CrossRef] [PubMed]
58. Kim, J.E.; Gordon, S.; Ferruzzi, M.; Campbell, W. Effects of whole egg consumption on carotenoids absorption from co-consumed, carotenoids-rich mixed-vegetable salad. FASEB J. 2015, 29, 1.
59. Goltz, S.R.; Campbell, W.W.; Chitchumroonchokchai, C.; Failla, M.L.; Ferruzzi, M.G. Meal triacylglycerol profile modulates postprandial absorption of carotenoids in humans. Mol. Nutr. Food Res. 2012, 56, 866-877. [CrossRef]
60. Reboul, E.; Thap, S.; Tourniaire, F.; Andre, M.; Juhel, C.; Morange, S.; Amiot, M.J.; Lairon, D.; Borel, P. Differential effect of dietary antioxidant classes (carotenoids, polyphenols, vitamins C and E) on lutein absorption. Br. J. Nutr. 2007, 97, 440-446. [CrossRef]
61. Riedl, J.; Linseisen, J.; Hoffmann, J.; Wolfram, G. Some dietary fibers reduce the absorption of carotenoids in women. J. Nutr. 1999, 129, 2170-2176. [CrossRef]
62. Van Het Hof, K.H.; West, C.E.; Weststrate, J.A.; Hautvast, J.G. Dietary factors that affect the bioavailability of carotenoids. J. Nutr. 2000, 130, 503-506. [CrossRef]
63. Hornero-Mendez, D.; Mínguez-Mosquera, M.-M. Bioaccessibility of carotenes from carrots: Effect of cooking and addition of oil. Innov. Food Sci. Emerg. Technol. 2007, 8, 407-412. [CrossRef]
64. Baskaran, V.; Sugawara, T.; Nagao, A. Phospholipids affect the intestinal absorption of carotenoids in mice. Lipids 2003, 38, 705-711. [CrossRef]
65. O'Connell, O.F.; Ryan, L.; O'Brien, N.M. Xanthophyll carotenoids are more bioaccessible from fruits than dark green vegetables. Nutr. Res. 2007, 27, 258-264. [CrossRef]
66. Prince, M.R.; Frisoli, J.K. Beta-carotene accumulation in serum and skin. Am. J. Clin. Nutr. 1993, 57, 175-181. [CrossRef]
67. Olson, J.A. Absorption, transport, and metabolism of carotenoids in humans. Pure Appl. Chem. 1994, 66, 1011-1016. [CrossRef]
68. Fernandez-Garcia, E.; Carvajal-Lerida, I.; Jaren-Galan, M.; Garrido-Fernandez, J.; Perez-Galvez, A.; Hornero-Mendez, D. Carotenoids bioavailability from foods: From plant pigments to efficient biological activities. Food Res. Int. 2012, 46, 438-450. [CrossRef]
69. Parker, R.S. Absorption, metabolism and transport of carotenoids. FASEB J. 1996, 10, 542-551. [CrossRef]
70. Erdman, J.W., Jr.; Bierer, T.L.; Gugger, E.T. Absorption and transport of carotenoids. Ann. N. Y. Acad. Sci. 1993, 691, 76-85. [CrossRef]
71. Rao, A.V.; Rao, L.G. Carotenoids and human health. Pharmacol. Res. 2007, 55, 207-216. [CrossRef]
72. Stahl, W.; Schwarz, W.; Sundquist, A.R.; Sies, H. cis-trans Isomers of lycopene and β-carotene in human serum and tissues. Arch. Biochem. Biophys. 1992, 294, 173-177. [CrossRef]
73. Darvin, M.E.; Sterry, W.; Landemann, J.; Vergou, T. The role of carotenoids in human skin. Molecules 2011, 16, 10491-10506. [CrossRef]
74. Castenmiller, J.J.M.; West, C.E. Bioavailability of carotenoids. Pure Appl. Chem. 1997, 69, 2145-2150. [CrossRef]
75. Yeum, K.-J.; Russell, R.M. Carotenoid bioavailability and bioconversion. Ann. Rev. Nutr. 2002, 22, 483-504. [CrossRef] [PubMed]
76. Nigam, Y.; Knight, J.; Bhattacharya, S.; Bayer, A. Physiological changes associated with aging and immobility. J. Aging Res. 2012, 2012. [CrossRef]
77. Navaratnarajah, A.; Jackson, S.H.D. The physiology of aging. Medicine 2017, 45, 6-10. [CrossRef]
78. Russell, R.M. Factors in aging that effect the bioavailability of nutrients. J. Nutr. 2001, 131, 1359S-1361S. [CrossRef]
79. Tang, G.W.; Serfaty-Lacrosniere, C.; Camilo, M.E.; Russell, R.M. Gastric acidity influences the blood response to a beta-carotene dose in humans. Am. J. Clin. Nutr. 1996, 64, 622-626. [CrossRef]
80. Farage, M.A.; Miller, K.W.; Elsner, P.; Maibach, H.I. Functional and physiological characteristics of the aging skin. Aging Clin. Exp. Res. 2008, 20, 195-200. [CrossRef]
81. Gholamian-Dehkordi, N.; Luther, T.; Asadi-Samani, M.; Mahmoudian-Sani, M.R. An overview on natural antioxidants for oxidative stress reduction in cancers; a systematic review. Immunopathol. Persa. 2017, 3, e12. [CrossRef]
82. Gaschler, M.M.; Stockwell, B.R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 2017, 482, 419-425. [CrossRef]
83. Shen, Y.; Li, J.; Gu, R.; Yue, L.; Wang, H.; Zhan, X.; Xing, B. Carotenoid and superoxide dismutase are the most effective antioxidants participating in ROS scavenging in phenanthrene accumulated wheat leaf. Chemosphere 2018, 197, 513-525. [CrossRef] [PubMed]
84. Miller, N.J.; Sampson, J.; Candeias, L.P.; Bramley, P.M.; Rice-Evans, C.A. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996, 384, 240-242. [CrossRef]
85. Krinsky, N.I. The antioxidant and biological properties of the carotenoids. Ann. N. Y. Acad. Sci. 1998, 854, 443-447. [CrossRef]
86. Eggersdorfer, M.; Wyss, A. Carotenoids in human nutrition and health. Arch. Biochem. Biophy. 2018, 652, 18-26. [CrossRef]
87. Prasad, K.N.; Wu, M.; Bondy, S.C. Telomere shortening during aging: Attenuation by antioxidants and anti-inflammatory agents. Mech. Ageing Dev. 2017, 164, 61-66. [CrossRef]
88. GBD 2015 DALYs; Hale Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1603-1658. [CrossRef]
89. Quillen, D.A. Common causes of vision loss in elderly patients. Am. Fam. Physician 1999, 60, 99-108.
90. Chen, Y.; Bedell, M.; Zhang, K. Age-related macular degeneration: Genetic and environmental factors of disease. Mol. Interv. 2010, 10, 271-281. [CrossRef]
91. Tosini, G.; Ferguson, I.; Tsubota, K. Effects of blue light on the circadian system and eye physiology. Mol. Vis. 2016, 22, 61-72.
92. Congdon, N.; O'Colmain, B.; Klaver, C.C.; Klein, R.; Muñoz, B.; Friedman, D.S.; Kempen, J.; Taylor, H.R.; Mitchell, P.; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122, 477-485.
93. Resnikoff, S.; Pascolini, D.; Etya'ale, D.; Kocur, I.; Pararajasegaram, R.; Pokharel, G.P.; Mariotti, S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004, 82, 844-851.
94. Wong, W.L.; Su, X.; Li, X.; Cheung, C.M.; Klein, R.; Cheng, C.-Y.; Wong, T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: Asystematic review and meta-analysis. Lancet Glob. Health 2014, 2, e106-e116. [CrossRef]
95. Eisenhauer, B.; Natoli, S.; Liew, G.; Flood, V.M. Lutein and zeaxanthin-food sources, bioavailability and dietary variety in age-related macular degeneration protection. Nutrients 2017, 9, 120. [CrossRef]
96. Blasiak, J.; Petrovski, G.; Veréb, Z.; Facskó, A.; Kaarniranta, K. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed Res. Int. 2014, 2014. [CrossRef] [PubMed]
97. Liu, X.-H.; Yu, R.B.; Liu, R.; Hao, Z.-X.; Han, C.-C.; Zhu, Z.-H.; Ma, L. Association between lutein and zeaxanthin status and the risk of cataract: A meta-analysis. Nutrients 2014, 6, 452-465. [CrossRef] [PubMed]
98. Age-Related Eye Disease Study 2 Research Group; Chew, E.Y.; SanGiovanni, J.P.; Ferris, F.L.; Wong, W.T.; Agron, E.; Clemons, T.E.; Sperduto, R.; Danis, R.; Chandra, S.R.; et al. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol. 2013, 131, 843-850. [CrossRef] [PubMed]
99. Bungau, S.; Abdel-Daim, M.M.; Tit, D.M.; Ghanem, E.; Sato, S.; Maruyama-Inoue, M.; Yamane, S.; Kadonosono, K. Health benefits of polyphenols and carotenoids in age-related eye diseases. Oxid. Med. Cell. Longev. 2019, 2019. [CrossRef]
100. Sandmann, G. Carotenoids of biotechnological importance. Adv. Biochem. Eng. Biotechnol. 2015, 148, 449-467. [PubMed]
101. Bernstein, P.S.; Li, B.; Vachali, P.P.; Gorusupudi, A.; Shyam, R.; Henriksen, B.S.; Nolan, J.M. Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog. Retin. Eye Res. 2016, 50, 34-66. [CrossRef]
102. Gonçalves, A.; Estevinho, B.N.; Rocha, F. Microencapsulation of vitamin A: A review. Trends Food Sci. Tech. 2016, 51, 76-87.
103. West, K.P. Epidemiology and prevention of vitamin A deficiency disorders. Retinoids Biol. Biochem. Dis. 2015, 505-527.
104. Hammond, B.R.; Fletcher, L.M.; Roos, F.; Wittwer, J.; Schalch, W. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Investig. Ophthalmol. Vis. Sci. 2014, 55, 8583-8589. [CrossRef] [PubMed]
105. Yao, Y.; Qiu, Q.H.; Wu, X.W.; Cai, Z.Y.; Xu, S.; Liang, X.Q. Lutein supplementation improves visual performance in Chinese drivers: 1-year randomized, double-blind, placebo-controlled study. Nutrition 2013, 29, 958-964. [CrossRef]
106. Nolan, J.M.; Power, R.; Stringham, J.; Dennison, J.; Stack, J.; Kelly, D.; Moran, R.; Akuffo, K.O.; Corcoran, L.; Beatty, S. Author response: Comments on enrichment of macular pigment enhances contrast sensitivity in subjects free of retinal disease: CREST-Report 1. Investig. Ophthalmol. Vis. Sci. 2016, 57, 5416. [CrossRef]
107. World Health Organization. Dementia. 2019. Available online: Https://www.who.int/news-room/fact-sheets/ detail/dementia (accessed on 5 March 2019).
108. Renzi, L.M.; Dengler, M.J.; Puente, A.; Miller, L.S.; Hammond, B.R.Jr. Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiol. Aging 2014, 35, 1695-1699. [CrossRef]
109. Feeney, J.; Finucane, C.; Savva, G.M.; Cronin, H.; Beatty, S.; Nolan, J.M.; Kenny, R.A. Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiol. Aging 2013, 34, 2449-2456. [CrossRef]
110. Rebecca, P.; Robert, C.; Stephen, B.; Riona, M.; Rachel, M.; Jim, S.; Alan, H.N.; John, N.M. Supplemental retinal carotenoids enhance memory in healthy individuals with low levels of macular pigment in a randomized, double-blind, placebo-controlled clinical trial. J. Alzheimer's Dis. 2018, 61, 947-961.
111. Rubin, L.P.; Ross, A.C.; Stephensen, C.B.; Bohn, T.; Tanumihardjo, S.A. Metabolic effects of inflammation on vitamin A and carotenoids in humans and animal models. Adv. Nutr. 2017, 8, 197-212. [CrossRef]
112. Jing, L.; Xiao, M.; Dong, H.; Lin, J.; Chen, G.; Ling, W.; Chen, Y. Serum carotenoids are inversely associated with RBP4 and other inflammatory markers in middle-aged and elderly adults. Nutrients 2018, 10, 260. [CrossRef]
113. Norseen, J.; Hosooka, T.; Hammarstedt, A.; Yore, M.M.; Kant, S.; Aryal, P.; Kiernan, U.A.; Phillips, D.A.; Maruyama, H.; Kraus, B.J.; et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through c-Jun N-terminal kinase- (JNK) and toll-like receptor 4-dependent and retinol-independent mechanism. Mol. Cell. Biol. 2012, 32, 2010-2019. [CrossRef]
114. Du, M.; Martin, A.; Hays, F.; Johnson, J.; Farjo, R.A.; Farjo, K.M. Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. Mol. Vis. 2017, 23, 185-197.
115. Moraes-Vieira, P.M.; Yore, M.M.; Dwyer, P.M.; Syed, I.; Aryal, P.; Kahn, B.B. RBP4 activates antigen-presenting cells leading to adipose tissue inflammation and systemic insulin resistance. Cell MeTable 2014, 19, 512-526. [CrossRef]
116. Christensen, K.; Gleason, C.E.; Mares, J.A. Dietary carotenoids and cognitive function among US adults, NHANES 2011-2014. Nutr. Neurosci. 2018, 1-9. [CrossRef] [PubMed]
117. Hadad, N.; Levy, R. Combination of EPA with carotenoids and polyphenol synergistically attenuated the transformation of microglia to M1 phenotype via inhibition of NF-κB. Neuromol. Med. 2017, 19, 436-451. [CrossRef]
118. Lin, H.-C.; Lin, M.-H.; Liao, J.-H.; Wu, T.-H.; Lee, T.-H.; Mi, F.-L.; Wu, C.H.; Chen, K.C.; Cheng, C.H.; Lin, C.W. Antroquinonol, a ubiquinone derivative from the mushroom Antrodia camphorata, inhibits colon cancer stem cell-like properties: Insights into the molecular mechanism and inhibitory targets. J. Agric. Food Chem. 2017, 65, 51-59. [CrossRef] [PubMed]
119. Wang, J.; Li, L.; Wang, Z.; Cui, Y.; Tan, X.; Yuan, T.; Liu, Q.; Liu, Z.; Liu, X. Supplementation of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress. J. Nutr. Biochem. 2018, 56, 16-25. [CrossRef] [PubMed]
120. Krishnaraj, R.N.; Kumari, S.S.; Mukhopadhyay, S.S. Antagonistic molecular interactions of photosynthetic pigments with molecular disease targets: A new approach to treat AD and ALS. J. Recept. Signal Transduct. 2016, 36, 67-71. [CrossRef]
121. Xiang, S.; Liu, F.; Lin, J.; Chen, H.; Huang, C.; Chen, L.; Zhou, Y.; Ye, L.; Zhang, K.; Jin, J.; et al. Fucoxanthin inhibits β-amyloid assembly and attenuates β-amyloid oligomer-induced cognitive impairments. J. Agric. Food Chem. 2017, 65, 4092-4102. [CrossRef] [PubMed]
122. Ono, K.; Yamada, M. Vitamin A and Alzheimer's disease. Geriatr. Gerontol. Int. 2012, 12, 180-188. [CrossRef] [PubMed]
123. Sachdeva, A.K.; Chopra, K. Lycopene abrogates Aβ (1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease. J. Nutr. Biochem. 2015, 26, 736-744. [CrossRef] [PubMed]
124. Min, J.Y.; Min, K.B. Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer's disease mortality in older adults. Dement. Geriatr. Cogn. Disord. 2014, 37, 246-256. [CrossRef]
125. World Health Organization. Cardiovascular Disease. 2019. Available online: Https://www.who.int/ cardiovascular_diseases/en/ (accessed on 5 March 2019).
126. Leening, M.J.; Ferket, B.S.; Steyerberg, E.W.; Kavousi, M.; Deckers, J.W.; Nieboer, D.; Heeringa, J.; Portegies, M.L.; Hofman, A.; Ikram, M.A.; et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: Prospective population based cohort study. BMJ 2014, 349, g5992. [CrossRef] [PubMed]
127. Siti, H.N.; Kamisah, Y.; Kamsiah, J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul. Pharmacol. 2015, 71, 40-56. [CrossRef]
128. Bugger, H.; Abel, E.D. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin. Sci. 2008, 114, 195-210. [CrossRef]
129. Lee, R.; Margaritis, M.; Channon, M.K.; Antoniades, C. Evaluating oxidative stress in human cardiovascular disease: Methodological aspects and considerations. Curr. Med. Chem. 2012, 19, 2504-2520. [CrossRef] [PubMed]
130. Thies, F.; Mills, L.M.; Moir, S.; Masson, L.F. Cardiovascular benefits of lycopene: Fantasy or reality? Proc. Nutr. Soc. 2017, 76, 122-129. [CrossRef]
131. Alvi, S.S.; Iqbal, D.; Ahmad, S.; Khan, M.S. Molecular rationale delineating the role of lycopene as a potent HMG-CoA reductase inhibitor: In vitro and in silico study. Nat. Prod. Res. 2016, 30, 2111-2114. [CrossRef]
132. Sandoval, V.; Rodríguez-Rodríguez, R.; Martínez-Garza, U.; Rosell-Cardona, C.; Lamuela-Raventós, R.M.; Marrero, P.F.; Haro, D.; Relat, J. Mediterranean tomato-based sofrito sauce improves fibroblast growth factor 21 (FGF21) signaling in white adipose tissue of obese ZUCKER rats. Mol. Nutr. Food Res. 2018, 62, 1700606. [CrossRef]
133. Chang, J.; Zhang, Y.; Li, Y.; Lu, K.; Shen, Y.; Guo, Y.; Qi, Q.; Wang, M.; Zhang, S. NrF2/ARE and NF-κB pathway regulation may be the mechanism for lutein inhibition of human breast cancer cell. Future Oncol. 2018, 14, 719-726. [CrossRef]
134. Chung, R.W.S.; Leanderson, P.; Lundberg, A.K.; Jonasson, L. Lutein exerts anti-inflammatory effects in patients with coronary artery disease. Atherosclerosis 2017, 262, 87-93. [CrossRef]
135. Maria, A.G.; Graziano, R.; Nicolantonio, D.O. Carotenoids: Potential allies of cardiovascular health? Food Nutr. Res. 2015, 59, 26762. [CrossRef]
136. Kishimoto, Y.; Taguchi, C.; Saita, E.; Suzuki-Sugihara, N.; Nishiyama, H.; Wang, W.; Masuda, Y.; Kondo, K. Additional consumption of one egg per day increases serum lutein plus zeaxanthin concentration and lowers oxidized low-density lipoprotein in moderately hypercholesterolemic males. Food Res. Int. 2017, 99, 944-949. [CrossRef]
137. Leermakers, E.T.; Darweesh, S.K.; Baena, C.P.; Moreira, E.M.; Melo van Lent, D.; Tielemans, M.J.; Muka, T.; Chowdhury, R.; Bramer, W.M.; Kiefte-de Jong, J.C.; et al. The effects of lutein on cardiometabolic health across the life course: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2016, 103, 481-494. [CrossRef]
138. Costa-Rodrigues, J.; Pinho, O.; Monteiro, P.R.R. Can lycopene be considered an effective protection against cardiovascular disease? Food Chem. 2018, 245, 1148-1153. [CrossRef]
139. Cheng, H.M.; Koutsidis, G.; Lodge, J.K.; Ashor, A.; Siervo, M.; Lara, J. Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis 2017, 257, 100-108. [CrossRef]
140. Greene, C.M.; Waters, D.; Clark, R.M.; Contois, J.H.; Fernandez, M.L. Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population. Nutr. MeTable 2006, 3, 6. [CrossRef] [PubMed]
141. Song, B.; Liu, K.; Gao, Y.; Zhao, L.; Fang, H.; Li, Y.; Pei, L.; Xu, Y. Lycopene and risk of cardiovascular diseases: A meta-analysis of observational studies. Mol. Nutr. Food Res. 2017, 61, 1601009. [CrossRef]
142. Osganian, S.K.; Stampfer, M.J.; Rimm, E.; Spiegelman, D.; Manson, J.E.; Willett, W.C. Dietary carotenoids and risk of coronary artery disease in women. Am. J. Clin. Nutr. 2003, 77, 1390-1399. [CrossRef] [PubMed]
143. Sesso, H.D.; Liu, S.; Gaziano, J.M.; Buring, J.E. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J. Nutr. 2003, 133, 2336-2341. [CrossRef]
144. Tavani, A.; Gallus, S.; Negri, E.; Parpinel, M.; La Vecchia, C. Dietary intake of carotenoids and retinol and the risk of acute myocardial infarction in Italy. Free Radic. Res. 2006, 40, 659-664. [CrossRef] [PubMed]
145. Li, X.; Xu, J. Dietary and circulating lycopene and stroke risk: A meta-analysis of prospective studies. Sci. Rep. 2014, 4, 5031. [CrossRef]
146. Borel, P.; Desmarchelier, C.; Nowicki, M.; Bott, R. Lycopene bioavailability is associated with a combination of genetic variants. Free Radic. Biol. Med. 2015, 83, 238-244. [CrossRef]
147. Zubair, N.; Kooperberg, C.; Liu, J.; Di, C.; Peters, U.; Neuhouser, M.L. Genetic variation predicts serum lycopene concentrations in a multiethnic population of postmenopausal women. J. Nutr. 2015, 145, 187-192. [CrossRef]
148. World Health Organization. Cancer. 2019. Available online: Https://www.who.int/cancer/en/ (accessed on 7 March 2019).
149. International Agency for Research on Cancer (IARC). Latest Global Cancer Data: Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Cancer Deaths in 2018. 2018. Available online: Https://www.who.int/ cancer/PRGlobocanFinal.pdf?ua=1 (accessed on 7 March 2019).
150. Liu, X.; Song, M.; Gao, Z.; Cai, X.; Dixon, W.; Chen, X.; Cao, Y.; Xiao, H. Stereoisomers of astaxanthin inhibit human colon cancer cell growth by inducing G2/M cell cycle arrest and apoptosis. J. Agric. Food Chem. 2016, 64, 7750-7759. [CrossRef]
151. Rafi, M.M.; Kanakasabai, S.; Gokarn, S.V.; Krueger, E.G.; Bright, J.J. Dietary lutein modulates growth and survival genes in prostate cancer cells. J. Med. Food 2015, 18, 173-181. [CrossRef] [PubMed]
152. Shareck, M.; Rousseau, M.C.; Koushik, A.; Siemiatycki, J.; Parent, M.-E. Inverse association between dietary intake of selected carotenoids and vitamin C and risk of lung cancer. Front. Oncol. 2017, 7, 23. [CrossRef]
153. Tuzcu, M.; Orhan, C.; Muz, O.E.; Sahin, N.; Juturu, V.; Sahin, K. Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model. BMC Ophthalmol. 2017, 17, 129. [CrossRef]
154. Cha, J.H.; Kim, W.K.; Ha, A.W.; Kim, M.H.; Chang, M.J. Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells. Nutr. Res. Pract. 2017, 11, 90-96. [CrossRef]
155. De Waart, F.G.; Schouten, E.G.; Stalenhoef, A.F.H.; Kok, F.J. Serum carotenoids, α-tocopherol and mortality risk in a prospective study among Dutch elderly. Int. J. Epidemiol. 2001, 30, 136-143. [CrossRef]
156. Aizawa, K.; Liu, C.; Tang, S.; Veeramachaneni, S.; Hu, K.Q.; Smith, D.E.; Wang, X.D. Tobacco carcinogen induces both lung cancer and nonalcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation. Int. J. Cancer 2016, 139, 1171-1181. [CrossRef] [PubMed]
157. Middha, P.; Weinstein, S.J.; Männistö, S.; Albanes, D.; Mondul, A.M. β-carotene supplementation and lung cancer incidence in the ATBC study: The role of tar and nicotine. Nicotine Tob. Res. 2018. [CrossRef] [PubMed]
158. Russell, R.M. Beta-carotene and lung cancer. Pure Appl. Chem. 2002, 74, 1461-1467. [CrossRef]
159. World Health Organization. Diabetes. 2019. Available online: Https://www.who.int/news-room/fact-sheets/ detail/diabetes (accessed on 7 March 2019).
160. Fowler, M.J. Microvascular and macrovascular complications of diabetes. Clin. Diabetes 2011, 29, 116-122. [CrossRef]
161. Ullah, A.; Khan, A.; Khan, I. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm. J. 2016, 24, 547-553.
162. Wang, J.; Light, K.; Henderson, M.; O'Loughlin, J.; Mathieu, M.E.; Paradis, G.; Gray-Donald, K. Consumption of added sugars from liquid but not solid sources predicts impaired glucose homeostasis and insulin resistance among youth at risk of obesity. J. Nutr. 2013, 144, 81-86. [CrossRef]
163. Yan, L.-J. Pathogenesis of chronic hyperglycemia: From reductive stress to oxidative stress. J. Diabetes Res. 2014, 2014. [CrossRef]
164. Wan, T.-T.; Li, X.-F.; Sun, Y.-M.; Li, Y.-B.; Su, Y. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. Biomed. Pharmacother. 2015, 74, 145-147. [CrossRef] [PubMed]
165. Newsholme, P.; Cruzat, V.F.; Keane, K.N.; Carlessi, R.; de Bittencourt, P.I.H., Jr. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem. J. 2016, 473, 4527-4550. [CrossRef]
166. Uchiyama, K.; Naito, Y.; Hasegawa, G.; Nakamura, N.; Takahashi, J.; Yoshikawa, T. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice. Redox Rep. 2002, 7, 290-293. [CrossRef]
167. Sluijs, I.; Cadier, E.; Beulens, J.W.; van der, A.D.; Spijkerman, A.M.; van der Schouw, Y.T. Dietary intake of carotenoids and risk of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 376-381. [CrossRef] [PubMed]
168. Arnlov, J.; Zethelius, B.; Riserus, U.; Basu, S.; Berne, C.; Vessby, B.; Alfthan, G.; Helmersson, J.; Uppsala Longitudinal Study of Adult Men Study. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: Report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study. Diabetologia 2009, 52, 97-105. [CrossRef] [PubMed]
169. Maeda, H.; Hosokawa, M.; Sashima, T.; Murakami-Funayama, K.; Miyashita, K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Rep. 2009, 2, 897-902. [CrossRef] [PubMed]
170. Manabe, E.; Handa, O.; Naito, Y.; Mizushima, K.; Akagiri, S.; Adachi, S.; Takagi, T.; Kokura, S.; Maoka, T.; Yoshikawa, T. Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling. J. Cell. Biochem. 2008, 103, 1925-1937. [CrossRef] [PubMed]
171. Kim, Y.J.; Kim, Y.A.; Yokozawa, T. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J. Agric. Food Chem. 2009, 57, 8793-8797. [CrossRef]
172. Akbaraly, T.N.; Fontbonne, A.; Favier, A.; Berr, C. Plasma carotenoids and onset of dysglycemia in an elderly population. Diabetes Care 2008, 31, 1355-1359. [CrossRef]
173. International Osteoporosis Foundation. Facts and Statistics. 2017. Available online: Https://www. iofbonehealth.org/facts-statistics (accessed on 8 March 2019).
174. Johnell, O.; Kanis, J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 2006, 17, 1726-1733. [CrossRef]
175. Melton, L.J., 3rd.; Crowson, C.S.; O'Fallon, W.M. Fracture incidence in Olmsted County, Minnesota: Comparison of urban with rural rates and changes in urban rates over time. Osteoporos. Int. 1999, 9, 29-37. [CrossRef]
176. Gullberg, B.; Johnell, O.; Kanis, J.A. World-wide projections for hip fracture. Osteoporos. Int. 1997, 7, 407. [CrossRef] [PubMed]
177. Astley, S.B.; Hughes, D.A.; Wright, A.J.; Elliott, R.M.; Southon, S. DNA damage and susceptibility to oxidative damage in lymphocytes: Effects of carotenoids in vitro and in vivo. Br. J. Nutr. 2004, 91, 53-61. [CrossRef]
178. Almeida, M.; Han, L.; Martin-Millan, M.; O'Brien, C.A.; Manolagas, S.C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 2007, 282, 27298-27305. [CrossRef] [PubMed]
179. Cao, W.T.; Zeng, F.F.; Li, B.L.; Lin, J.S.; Liang, Y.Y.; Chen, Y.M. Higher dietary carotenoid intake associated with lower risk of hip fracture in middle-aged and elderly Chinese: A matched case-control study. Bone 2018, 111, 116-122. [CrossRef]
180. Dai, Z.; Wang, R.; Ang, L.W.; Low, Y.L.; Yuan, J.M.; Koh, W.P. Protective effects of dietary carotenoids on risk of hip fracture in men: The Singapore Chinese Health Study. J. Bone Miner. Res. 2014, 29, 408-417. [CrossRef]
181. Zhang, Z.Q.; Cao, W.T.; Liu, J.; Cao, Y.; Su, Y.X.; Chen, Y.M. Greater serum carotenoid concentration associated with higher bone mineral density in Chinese adults. Osteoporos. Int. 2016, 27, 1593-1601. [CrossRef] [PubMed]
182. Li, H.; Huang, C.; Zhu, J.; Gao, K.; Fang, J.; Li, H. Lutein suppresses oxidative stress and inflammation by Nrf2 activation in an osteoporosis rat model. Med. Sci. Monit. 2018, 24, 5071-5075. [CrossRef]
183. Tominari, T.; Matsumoto, C.; Watanabe, K.; Hirata, M.; Grundler, F.M.W.; Inada, M.; Miyaura, C. Lutein, a carotenoid, suppresses osteoclastic bone resorption and stimulates bone formation in cultures. J. Biosci. Biotechnol. Biochem. 2017, 81, 302-306. [CrossRef] [PubMed]
184. Bovier, E.R.; Hammond, B.R. The macular carotenoids lutein and zeaxanthin are related to increased bone density in young healthy adults. Foods 2017, 6, 78. [CrossRef]
185. Willis, L.M.; Shukitt-Hale, B.; Joseph, J.A. Modulation of cognition and behavior in aged animals: Role for antioxidant- and essential fatty acid-rich plant foods. Am. J. Clin. Nutr. 2009, 89, 1602-1606. [CrossRef]
186. Zhang, Z.; Han, S.; Wang, H.; Wang, T. Lutein extends the lifespan of Drosophila melanogaster. Arch. Gerontol. Geriatr. 2014, 58, 153-159. [CrossRef]
187. Neena, P.; Thomas, K.; Cynthia, H.; Shannon, H.; Rosemarie, A.; Marvin, T.; Salvador, G. Regulation of the extracellular matrix remodeling by lutein in dermal fibroblasts, melanoma cells, and ultraviolet radiation exposed fibroblasts. Arch. Dermatol. Res. 2007, 299, 373-379.
188. Bahrami, H.; Melia, M.; Dagnelie, G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial. BMC Ophthalmol. 2006, 6, 23. [CrossRef] [PubMed]
189. Yazaki, K.; Yoshikoshi, C.; Oshiro, S.; Yanase, S. Supplemental cellular protection by a carotenoid extends lifespan via Ins/IGF-signaling in Caenorhabditis elegans. Oxid. Med. Cell. Longev. 2011, 2011. [CrossRef]
190. Giannakou, M.E.; Goss, M.; Junger, M.A.; Hafen, E.; Leevers, S.J.; Partridge, L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 2004, 305, 361. [CrossRef] [PubMed]
191. Lashmanova, E.; Proshkina, E.; Zhikrivetskaya, S.; Shevchenko, O.; Marusich, E.; Leonov, S.; Melerzanov, A.; Zhavoronkov, A.; Moskalev, A. Fucoxanthin increases lifespan of Drosophila melanogaster and Caenorhabditis elegans. Pharmacol. Res. 2015, 100, 228-241. [CrossRef]
192. Johnson, E.J. Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr. Rev. 2014, 72, 605-612. [CrossRef] [PubMed]
193. Ravikrishnan, R.; Rusia, S.; Ilamurugan, G.; Salunkhe, U.; Deshpande, J.; Shankaranarayanan, J.; Shankaranarayana, M.L.; Soni, M.G. Safety assessment of lutein and zeaxanthin (Lutemax 2020): Subchronic toxicity and mutagenicity studies. Food Chem. Toxicol. 2011, 49, 2841-2848. [CrossRef] [PubMed]
194. Harikumar, K.B.; Nimita, C.V.; Preethi, K.C.; Kuttan, R.; Deshpande, J. Toxicity profile of lutein and lutein ester isolated from marigold flowers (Tagetes erecta). Int. J. Toxicol. 2008, 27, 1-9. [CrossRef]
195. Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids; National Academies Press (US):Washington, DC, USA, 2000.
196. Joint, F.A.O. Evaluation of Certain Food Additives: Sixty-Third Report of the Joint FAO/WHO Expert Committee on Food Additives; World Health Organization: Geneva, Switzerland, June 2004; pp. 23-26.
197. European Food Safety Authority. Scientific opinion on the re-evaluation of lutein [e 161b] as a food additive. EFSA J. 2010, 8, 1678. [CrossRef]
198. European Food Safety Authority (EFSA). Safety, bioavailability and suitability of lutein for the particular nutritional use by infants and young children-Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. EFSA J. 2008, 823, 1-24.
199. Zheng, Y.F.; Bae, S.H.; Kwon, M.J.; Park, J.B.; Choi, H.D.; Shin, W.G.; Bae, S.K. Inhibitory effects of astaxanthin, b-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin on cytochrome P450 enzyme activities. Food Chem. Toxicol. 2013, 59, 78-85. [CrossRef] [PubMed]
200. Amengual, J.; Lobo, G.P.; Golczak, M.; Li, H.N.; Klimova, T.; Hoppel, C.L.; Wyss, A.; Palczewski, K.; von Lintig, J. A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J. 2011, 25, 948-959. [CrossRef]
201. Olmedilla, B.; Granado, F.; Southon, S.; Wright, A.J.; Blanco, I.; Gil-Martinez, E.; van den Berg, H.; Thurnham, D.; Corridan, B.; Chopra, M.; et al. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: Analysis of serum responses. Clin. Sci. 2002, 102, 447-456. [CrossRef]
202. Satia, J.A.; Littman, A.; Slatore, C.G.; Galanko, J.A.; White, E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: Results from the Vitamins and Lifestyle (VITAL) study. Am. J. Epidemiol. 2009, 169, 815-828, Erratum in 2009, 169, 1409. [CrossRef] [PubMed]
203. Choi, R.Y.; Chortkoff, S.C.; Gorusupudi, A.; Bernstein, P.S. Crystalline maculopathy associated with high-dose lutein supplementation. JAMA Ophthalmol. 2016, 134, 1445-1448. [CrossRef]
204. Buscemi, S.; Corleo, D.; Di Pace, F.; Petroni, M.L.; Satriano, A.; Marchesini, G. The effect of lutein on eye and extra-eye health. Nutrients 2018, 10, 1321. [CrossRef]
205. Gorusupudi, A.; Nelson, K.; Bernstein, P.S. The age-related eye disease 2 study: Micronutrients in the treatment of macular degeneration. Adv. Nutr. 2017, 8, 40-53. [CrossRef]